Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 연만희, 주식회사 유한양행filedCritical연만희
Priority to KR1019920013789ApriorityCriticalpatent/KR940001888A/en
Publication of KR940001888ApublicationCriticalpatent/KR940001888A/en
본 발명은 항진균성 이미다졸 화합물에 살리실산을 첨가한 신규의 항진균제 조성물로서 약물의 피부각질 침투를 개선하여 치료효과를 높인 것이다.The present invention is a novel antifungal composition in which salicylic acid is added to an antifungal imidazole compound to improve the skin keratin penetration of the drug to enhance the therapeutic effect.
Description
신규의 항진균제 조성물Novel Antifungal Compositions
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (2)
항진균성 활성 성분인 이미다졸화합물에 살리실산을 1 : 10 내 지 10 : 1의 비율로 첨가하여 이루어짐을 특징으로 하는 항진균제 조성물.An antifungal drug composition comprising salicylic acid added to an imidazole compound as an antifungal active ingredient in a ratio of 1:10 to 10: 1.제1항에서, 항진균성 이미다졸를 화합물이 클로트리마졸 또는 미코나졸 또는 에코나졸 또는 옥시코나졸 또는 이소코나졸 또는 케토코나졸 또는 에틸코나졸 또는 비포코나졸 또는 설코나졸 또는 티오코나졸 또는 펜티코나졸임을 특징으로 하는 항진균제 조성물.The antifungal imidazole compound of claim 1, wherein the compound is selected from clotrimazole or myconazole or econazol or oxyconazole or isoconazole or ketoconazole or ethylconazole or bipoconazole or sulfonazole or thiconazole or penticona Antifungal composition, characterized in that it boils.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
HYDRATED SALTS OF N, N'-DIACETILCISTINA, PROCESS FOR ITS PREPARATION, AND THERAPEUTIC COMPOSITIONS THAT INCLUDE SUCH SALTS AS AN ACTIVE INGREDIENT.